Skip to content

Comparing Powered Ported Bone Marrow Aspiration to Manual Standard Bone Marrow Aspiration Procedures

A Study Comparing Powered Ported Bone Marrow Aspiration Procedures to Manual Standard Bone Marrow Aspiration Procedures Using Healthy Volunteers

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02299102
Enrollment
15
Registered
2014-11-24
Start date
2014-12-01
Completion date
2014-12-01
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Aspiration Procedures, Bone Marrow, powered ported bone marrow aspiration procedures

Brief summary

This single center study will compare the manual standard bone marrow aspiration device to the powered ported bone marrow aspiration device for use in the iliac crest in healthy adult volunteers. The study will evaluate the subjects' perceived level of pain, time to sample acquisition, and quality of specimen yield of these devices. Each subject will receive bilateral bone marrow aspiration procedures using both the manual standard and powered ported devices.

Detailed description

This single center study will compare the manual standard bone marrow aspiration device to the powered ported bone marrow aspiration device for use in the posterior iliac crest of healthy adult volunteers for bone marrow aspiration specimen collection. The study will evaluate the quality of specimen yield of the devices, subject reported level of pain with needle insertion and aspiration, and time from needle/periosteum contact to needle insertion and to sample acquisition. Each subject will receive bilateral bone marrow aspiration procedures using both the manual standard and power ported needles. Subjects were randomized for which device procedure was performed first. The second procedure was performed using the other device.

Interventions

DEVICEJamshidi Manual Standard Device

Jamshidi Manual Standard Device

DEVICEOnControl Powered Ported Device

OnControl Powered Ported Device

Sponsors

Vidacare Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Subject were randomized to determine which device procedure was performed first. Subjects randomized to Group 1 received the Jamshidi Manual Standard device procedure first and the OnControl Powered Ported device procedure second. Subjects ranomized to Group 2 received the OnControl Powered Ported device procedure first and the Jamshidi Manual Standard device procedure second.

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults 21 years of age and over * Able to lay flat in prone position on a table for up to 1 hour * Self-reported as healthy, as confirmed by the investigator during the medical history review and physical examination * Female subjects with a negative urine pregnancy test at screening visit

Exclusion criteria

* Reported fever within 7 days of the screening visit * Reported active infection within 7 days of the screening visit * Fever on day of study procedure * Signs/symptoms of active infection on day of study procedure * Imprisoned * Self identified as pregnant or lactating * Cognitively impaired * Patients with one or more conditions precluding bone marrow aspiration * Excessive tissue and/or absence of adequate anatomical landmarks in target bone * Allergy to local anesthetics * Unable to lay flat in prone position * Prothrombin time and International Normalized Ratio (PT/INR) results outside of normal range on screening lab work and deemed clinically significant by the investigator

Design outcomes

Primary

MeasureTime frameDescription
Quality of Aspirate Specimen Yield Total Score -Jamshidi Manual Standard Deviceanalyzed and results received within 30 days of Day 1 proceduresThe Quality of Aspirate Specimen Yield Total Score is a sum score using the 3 quality rating scales below. The Score range: 0 to 8; Higher scores mean greater quality. Direct Smears- Cellularity: 0= obviously dilute, no good particles or adequate megakaryocytes (MK) 1. probably slightly dilute, particles and MK present 2. cellular, good particles; MK present on edge, smears reflect clot section cellularity Particle Crush Smears: Evaluate presence of particles and quality of cellularity: 0= no particles 1. few particles; difficult to evaluate marrow cellularity and adequacy of MK 2. good particles; adequate material to evaluate MK 3. many particles, some large, with MK easily evaluated Clot Sections: Evaluate quantity and quality of particles 0= insufficient or no particles for interpretation 1. few small particles; difficult to determine cellularity 2. several particles, good marrow cellularity 3. numerous particles (some large); easy to assess cellularity and cell composition
Quality of Aspirate Specimen Yield Total Score -OnControl Power Ported Deviceanalyzed and results received within 30 days of Day 1 proceduresThe Quality of Aspirate Specimen Yield Total Score is a sum score using the 3 quality rating scales below. The Score range: 0 to 8; Higher scores mean greater quality. Direct Smears- Cellularity: 0= obviously dilute, no good particles or adequate megakaryocytes (MK) 1. probably slightly dilute, particles and MK present 2. cellular, good particles; MK present on edge, smears reflect clot section cellularity Particle Crush Smears: Evaluate presence of particles and quality of cellularity: 0= no particles 1. few particles; difficult to evaluate marrow cellularity and adequacy of MK 2. good particles; adequate material to evaluate MK 3. many particles, some large, with MK easily evaluated Clot Sections: Evaluate quantity and quality of particles 0= insufficient or no particles for interpretation 1. few small particles; difficult to determine cellularity 2. several particles, good marrow cellularity 3. numerous particles (some large); easy to assess cellularity and cell composition

Secondary

MeasureTime frameDescription
Level of Pain With Needle Insertion- Jamshidi Manual Standard DeviceDay 1 at time of procedureSubject reported level of pain with needle insertion (insertion of the bone marrow aspiration device, OnControl or Jamshidi, into the bone marrow space of the iliac crest) was reported by the patients for each procedure performed using the Wong-Baker FACES Pain Rating Scale Where 0 = no hurt and 10 = hurts worst. Higher numbers indicate greater pain.
Level of Pain With Needle Insertion- OnControl Power Ported DeviceDay 1 at time of procedureSubject reported level of pain with needle insertion (insertion of the bone marrow aspiration device, OnControl or Jamshidi, into the bone marrow space of the iliac crest) was reported by the patients for each procedure performed using the Wong-Baker FACES Pain Rating Scale Where 0 = no hurt and 10 = hurts worst. Higher numbers indicate greater pain.
Level of Pain With Aspiration - Jamshidi Manual Standard Device1 Day at time of the procedureSubject reported level of pain with aspiration (withdrawing the bone marrow aspirate specimen with syringe) was reported by the patients for each procedure performed using the Wong-Baker FACES Pain Rating Scale Where 0 = no hurt and 10 = hurts worst. Higher numbers indicate greater pain.
Level of Pain With Aspiration - OnControl Power Ported Device1 Day at time of the procedureSubject reported level of pain with aspiration (withdrawing the bone marrow aspirate specimen with syringe) was reported by the patients for each procedure performed using the Wong-Baker FACES Pain Rating Scale Where 0 = no hurt and 10 = hurts worst. Higher numbers indicate greater pain.
Time to Insertion - Jamshidi Manual Standard Device1 Day, during procedureTime recorded in seconds from contact of the device and the periosteum of the iliac crest to insertion of the needle through the cortex into the medullary space
Time to Insertion - OnControl Power Ported Device1 Day, during procedureTime recorded in seconds from contact of the device and the periosteum of the iliac crest to insertion of the needle through the cortex into the medullary space
Time for Aspirate Collection - Jamshidi Manual Standard Device1 Day, during procedureTime recorded in seconds from contact of the device and the periosteum of the iliac crest to removal of the needle from the medullary cavity following aspirate sample acquisition
Time for Aspirate Collection - OnControl Power Ported Device1 Day, during procedureTime recorded in seconds from contact of the device and the periosteum of the iliac crest to removal of the needle from the medullary cavity following aspirate sample acquisition

Countries

United States

Participant flow

Recruitment details

15 healthy adults were recruited to receive bilateral bone marrow aspiration procedures, one procedure using the Jamshidi Manual Standard Device and one procedure using the OnControl Powered Ported Device.

Pre-assignment details

All subjects received both study arms by receiving bilateral bone marrow aspiration from the iliac crest (right side and left side) using the Jamshidi manual standard device and the OnControl power ported aspiration needle device. Subjects were randomized to determine which device procedure was performed first and were assigned to Group 1 or Group 2.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 15
other
Total, other adverse events
4 / 152 / 15
serious
Total, serious adverse events
0 / 150 / 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026